Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/82058
PIRA download icon_1.1View/Download Full Text
DC FieldValueLanguage
dc.contributorDepartment of Applied Biology and Chemical Technology-
dc.creatorLee, MYen_US
dc.creatorHan, Yen_US
dc.creatorChoi, CLZhang, Zen_US
dc.creatorCui, Wen_US
dc.date.accessioned2020-05-05T05:58:29Z-
dc.date.available2020-05-05T05:58:29Z-
dc.identifier.urihttp://hdl.handle.net/10397/82058-
dc.language.isoenen_US
dc.rightsAssignee: University of Macauen_US
dc.rightsAssignee: The Hong Kong Polytechnic Universityen_US
dc.titleUses of indole-ketones or indolidones as neuro-protective drugsen_US
dc.typePatenten_US
dc.description.otherinformationUS9486440; US9486440 B2; US9486440B2; US9,486,440; US9,486440 B2; 9486440; 15/836,54014/354,137en_US
dcterms.abstractThe present invention provides a method of using indole-ketone or indolidone such as SU4312, SU5416, SU11248 (Sunitinib), or indirubin-3-oxime to treat a neurodegenerative disease or disorder such as Parkinson's disease which is associated with excessive neuronal Nitric Oxide Synthase (nNOS) activity.-
dcterms.bibliographicCitationUS Patent US9,486440 B2. Washington, DC: US Patent and Trademark Office, 2016.en_US
dcterms.issued2016-11-08-
dc.description.countryUS-
dc.description.validate202006 bcrc-
dc.description.oaVersion of Recorden_US
Appears in Collections:Patent
Files in This Item:
File Description SizeFormat 
us9486440b2.pdf4.98 MBAdobe PDFView/Open
Show simple item record

Page views

11
Citations as of Jun 19, 2022

Downloads

5
Citations as of Jun 19, 2022

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.